StockData
Aktis Oncology, Inc. logo

Aktis Oncology, Inc. (AKTS) stock

AKTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$16.31+0.15 (+0.93%)

Close on Nov 17, 2026Market cap $907.15MP/E –Yield –

Aktis Oncology EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.54–
Q2 FY2026Jun 30, 2026-$0.44–
Q1 FY2026Mar 31, 2026-$0.38–
Q3 FY2025Sep 30, 2025-$19.18–
Q2 FY2025Jun 30, 2025-$22.39–
Q1 FY2025Mar 31, 2025-$18.60–

More Aktis Oncology figures

See a number that looks wrong?